# data[].attributes.attachment_link.readable_text
Deerfield's Takeda will get $19.8 million from the federal government to develop a vaccine for the Zika virus.

Takeda Vaccines, a subsidiary of Japanese drugmaker Takeda Pharmaceutical Co., will get the funding over the next 18 months, according to the U.S. Department of Health and Human Services. Takeda's commercial U.S. headquarters is in Deerfield.

The company started working on the vaccine months ago with the intention of seeking federal funding to complete the work, said Dr. Rajeev Venkayya, president of Takeda's global vaccine business unit. Takeda will use the federal dollars to complete studies on the possible vaccine so it can file an application with the U.S. Food...

# data[].attributes.attachment_link.title
U.S. Department of Health and Human Services

# data[].attributes.attachment_link.description
Deerfield's Takeda will get $19.8 million from the federal government to develop a vaccine for the Zika virus. Takeda Vaccines, a subsidiary of Japanese drugmaker Takeda Pharmaceutical Co., will get the funding over the next 18 months, according to the U.S. Department of Health and Human Services. Takeda's commercial U.S.